U.S. Rep. Diana Harshbarger (R-Morristown) | Patient Daily

U.S. Rep. Diana Harshbarger (R-Morristown)

Patient Daily | May 31, 2024

US Reps. Bucshon, Carter, Harshbarger introduce legislation for transparency of 340B drug program

Trending

Patient Daily | Oct 9, 2025

Medfluence Advisors Marketing Expert: 'The conversations leading into AAO-HNSF are shaping how ENT practices approach growth and engagement'

Patient Daily | Oct 14, 2025

Mackinac Center raises concerns over federal 340B drug pricing program’s market impact

Patient Daily | Oct 9, 2025

AI takes center stage at ASCENT ENT conference, reshaping marketing and operations

+ Pharmaceuticals

Patient Daily | Oct 13, 2025

Cardinal Institute policy analyst: 340B program 'has quietly become a $40B side business'